GlaxoSmithKline (Multiple Sclerosis Drug) Overview

  • Founded
  • 1935
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

GlaxoSmithKline (Multiple Sclerosis Drug) General Information

Description

Developer of medicine. The company develops drugs for the treatment of multiple sclerosis disease and cancer in the United Kingdom.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Primary Office
  • 980 Great West Road
  • Brentford TW8 9GS
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GlaxoSmithKline (Multiple Sclerosis Drug) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GlaxoSmithKline (Multiple Sclerosis Drug)‘s full profile, request access.

Request a free trial

GlaxoSmithKline (Multiple Sclerosis Drug) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GlaxoSmithKline (Multiple Sclerosis Drug)‘s full profile, request access.

Request a free trial